KellySchoenbeckMD

PubMed

• 11 citations
  Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions.
  Kelly L. Schoenbeck, Kathryn E. Flynn
  Current Hematologic Malignancy Reports. 2021-10-14
• 11 citations
  Patient-Reported Functional Outcomes in Patients with Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitors.
  Kelly L. Schoenbeck, Ehab Atallah, Li Lin, Kevin P. Weinfurt, Jorge E. Cortes
  Journal of the National Cancer Institute. 2021-09-07
• 4 citations
  Circumstances around falls in older adults with Cancer
  Ursulina Tomczak, Schroder Sattar, Kelly L. Schoenbeck, Theresa Cordner, Tanya M. Wildes
  Journal of Geriatric Oncology. 2021-01-01

Abstracts/Posters

• Cognitive Dysfunction Associated with Tyrosine Kinase Inhibitors in Patients with CML in Chronic Phase
  Kelly L. Schoenbeck, MD, Sirisha Tummala, MD, Neha G. Goyal, PhD, Catherine C. Smith, MD and Neil P. Shah, MD, PhD, 62nd American Society of Hematology Annual Meeting & Exposition, 12/6/2020
• Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
  Kelly L. Schoenbeck, MD , Giselle Salmasi, MD , Miguel Carlos Cerejo, DO , Patricia A. Cornett, MD , Lloyd E. Damon, MD , Aaron C. Logan, MD PhD , Rebecca L. Olin, MD ..., 61st American Society of Hematology Annual Meeting & Exposition, Orlando, FL, 12/7/2019